- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 16.04. | Marimed Inc: Marimed to release Q1 results May 13 | 1 | Stockwatch | ||
| 15.04. | MariMed Inc.: MariMed Announces First Quarter 2026 Earnings Date | 2 | GlobeNewswire (USA) | ||
| 12.03. | MARIMED INC. - 10-K, Annual Report | 1 | SEC Filings | ||
| 12.03. | MariMed outlines 2026 growth strategy as wholesale revenue rises 11% and new state expansions advance | 5 | Seeking Alpha | ||
| 11.03. | MariMed Non-GAAP EPS of $2.20 beats by $2.21, revenue of $41.7M beats by $0.9M | 3 | Seeking Alpha | ||
| 11.03. | MariMed Inc.: MariMed Reports Fourth Quarter and Full Year 2025 Earnings | 196 | GlobeNewswire (Europe) | NORWOOD, Mass., March 11, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. ("MariMed" or the "Company") (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day... ► Artikel lesen | |
| 10.03. | An Overview of MariMed's Earnings | 1 | Benzinga.com | ||
| MARIMED Aktie jetzt für 0€ handeln | |||||
| 02.03. | MariMed Inc.: MariMed Extends Series B Preferred Stock Obligation Through 2031, Strengthening Capital Structure | 78 | GlobeNewswire (Europe) | NORWOOD, Mass., March 02, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. ("MariMed" or "the Company") (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today... ► Artikel lesen | |
| 11.02. | Marimed Inc: Marimed to release 2025 results March 11 | 2 | Stockwatch | ||
| 11.02. | MariMed Inc.: MariMed Announces Fourth Quarter and Full Year 2025 Earnings Date | 1 | GlobeNewswire (USA) | ||
| 05.02. | Marimed Inc: Marimed's Betty's Eddies launches Berry In Love Betty | 2 | Stockwatch | ||
| 22.01. | Marimed Inc: Marimed rolls out Vibations THC in Rhode Island | 3 | Stockwatch | ||
| 22.01. | MariMed Inc.: MariMed Launches Hemp-Derived THC Products Under its Vibations Brand in Rhode Island | 1 | GlobeNewswire (USA) | ||
| 19.12.25 | Marimed Inc: Marimed welcomes cannabis as Schedule 3 drug in U.S. | 2 | Stockwatch | ||
| 18.12.25 | MariMed Inc.: MariMed Statement on Historic Rescheduling of Cannabis | 156 | GlobeNewswire (Europe) | NORWOOD, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. ("MariMed") (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator committed to improving lives every day, issued the following... ► Artikel lesen | |
| 08.12.25 | MariMed Inc.: Veterans Healing Journey Becomes Soundtrack of Thrive Dispensaries | 2 | GlobeNewswire (USA) | ||
| 18.11.25 | Marimed Inc: Marimed adds winter cranberry orange Betty's chew | 2 | Stockwatch | ||
| 18.11.25 | MariMed Inc.: MariMed's Betty's Eddies Introduces New Limited-Edition Winter Seasonal Cranberry Orange Fruit Chew, Bundle Up Betty's | 1 | GlobeNewswire (USA) | ||
| 06.11.25 | MariMed GAAP EPS of -$0.01, revenue of $40.76M misses by $1.39M | 4 | Seeking Alpha | ||
| 06.11.25 | MARIMED INC. - 10-Q, Quarterly Report | - | SEC Filings |
1 2 Weiter >>
29 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 2,872 | -0,62 % | Globaler Mega-Deal: Bioxyne und Aurora Cannabis könnten den Markt umkrempeln! | ||
| ABBVIE | 169,45 | -0,06 % | Weekly Buzz: Sanofi, Regeneron Pharmaceuticals Get FDA Nod; It's A No For AbbVie, Grace Therapeutics; Eli Lilly Acquires Kelonia | NEW BRUNSWICK (dpa-AFX) - This week's biotech landscape witnessed regulatory approvals across the U.S. and Europe, alongside FDA rejections, acquisitions, and positive data readouts spanning... ► Artikel lesen | |
| CANOPY GROWTH | 1,016 | +0,74 % | Canopy Growth Is Rallying Again. But Is It a Dead Cat Bounce? | ||
| TILRAY BRANDS | 5,800 | +0,87 % | Tilray-Aktie: Neue Verkaufswelle in Anmarsch? | Nach einem Hochpunkt im Handelsjahr 2025 bei 23,20 US$ verabschiedete sich die Tilray-Aktie von eben diesen Kursniveaus und rauschte unter hoher Volatilität bis zum finalen Tief des Vormonats bei 5... ► Artikel lesen | |
| INNOCAN PHARMA | 3,910 | -3,22 % | ANALYSE: InnoCan Pharma: Warum erfahrene Anleger zum Wochenstart die Reißleine ziehen - Was Monday-Trader jetzt wissen sollten | ||
| TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | TAAT Global Alternatives Inc (2): TAAT Global CEO Saxon resigns | ||
| DERMAPHARM | 45,700 | -0,65 % | EQS-NVR: Dermapharm Holding SE: Veröffentlichung der Gesamtzahl der Stimmrechte nach § 41 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Gesamtstimmrechtsmitteilung: Dermapharm Holding SE
/ Veröffentlichung der Gesamtzahl der Stimmrechte
Dermapharm Holding SE: Veröffentlichung der Gesamtzahl der Stimmrechte... ► Artikel lesen | |
| CRONOS GROUP | 2,306 | +0,96 % | Cronos Group Inc: Cronos to hold Q1 results call May 11 | ||
| SYNBIOTIC | 2,010 | 0,00 % | EQS-News: SYNBIOTIC SE: SYNBIOTIC startet mit operativem Fortschritt, neuen regulatorischen Impulsen und starker Branchenpräsenz ins Frühjahr 2026 | EQS-News: SYNBIOTIC SE
/ Schlagwort(e): Marktbericht/Prognose
SYNBIOTIC startet mit operativem Fortschritt, neuen regulatorischen Impulsen und starker Branchenpräsenz ins Frühjahr... ► Artikel lesen | |
| DIGICANN VENTURES | 0,004 | -12,50 % | Digicann Ventures Inc.: Digicann Ventures Announces Resignation of Director | Vancouver, British Columbia--(Newsfile Corp. - April 8, 2026) - Digicann Ventures Ltd. (CSE: DCNN.X) ("Digicann" or the "Company"), a company focused on opportunities within and outside of the cannabis... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 1,224 | -0,81 % | Organigram Global Inc.: Organigram Closes Previously Announced Acquisition of Sanity Group, Private Placement Financing with BAT and ATB Senior Secured Credit Facilities | Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram") and Sanity Group GmbH ("Sanity" or "Sanity Group") jointly announced the successful closing of Organigram's previously... ► Artikel lesen | |
| GREEN THUMB INDUSTRIES | 6,230 | +0,48 % | Green Thumb Industries Inc: Green Thumb adds $100-million of share buyback capacity | ||
| SNDL | 1,315 | +1,70 % | SNDL Inc.: SNDL Announces Leadership Transition for Cannabis Segment | EDMONTON, Alberta, March 30, 2026 (GLOBE NEWSWIRE) -- SNDL Inc. (NASDAQ: SNDL, CSE: SNDL) ("SNDL" or the "Company") announced today that Tyler Robson, President of Cannabis, has left the Company in... ► Artikel lesen | |
| CRESCO LABS | 0,892 | +1,59 % | Cresco Labs Inc: Cresco Labs welcomes U.S. medical cannabis rescheduling | ||
| NOVERIS HEALTH SCIENCES | 0,970 | -18,49 % | XFRA 0NF1: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen |
MARIMED INC gehört der Branche Pharma an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MARIMED INC finden Sie auf Wallstreet Online.